Alliance Global Partners lowered the firm’s price target on Advanced Flower Capital (AFCG) to $10 from $13 and keeps a Buy rating on the shares. Advanced Flower’s Q4 net interest income and distributable EPS were below estimates, primarily due to lower than expected income from Justice Grown, that is taking legal action against its New Jersey CRO, with implications on Advacned Flower in the suit, giving uncertainty regarding income from one of its largest loans in the near-term, the analyst tells investors in a research note. While the issues with Justice Cannabis cause a step down as the borrower returns to being an issue, the firm believes this is now embedded in the stock.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFCG:
- Advanced Flower Capital downgraded to Hold from Buy at Jefferies
- Advanced Flower Capital Reports 2024 Financial Results
- AFC Gamma’s Earnings Call: Mixed Results Amid Challenges
- Advanced Flower Capital reports Q4 distributable EPS 29c, consensus 36c
- Advanced Flower Capital provides $15M senior secured credit facility to Story